array(3) { ["company_details"]=> array(13) { ["name"]=> string(28) "Bristol-Myers Squibb Company" ["slug"]=> string(37) "81631-us-bristol-myers-squibb-company" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/7b41874f-2658-484b-890c-9b9bd5a41f13" ["description"]=> string(1400) "At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html" ["address_street"]=> string(19) "430 E 29TH St FL 14" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1887-02-28" ["website_domain"]=> string(7) "bms.com" ["website_url"]=> string(19) "https://www.bms.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(1200) ["article_count"]=> int(2511) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(34) "BMS TEL WILL NOT DISTRIBUTE PROFIT" ["snippet_en"]=> string(72) "BMS Birleşik Metal Sanayi ve Ticaret A.Ş. will not distribute profits." ["url"]=> string(70) "https://www.analizgazetesi.com.tr/haber/bms-tel-kar-dagitmayacak-1956/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2ac5387b-9a7b-4740-8838-ad64ffd43f07" ["source"]=> string(21) "analizgazetesi.com.tr" ["publication_date"]=> string(10) "2024-04-05" ["categories"]=> array(4) { [0]=> string(5) "Taxes" [1]=> string(10) "Tax Havens" [2]=> string(31) "Financial Update/Profit Warning" [3]=> string(11) "Tax evasion" } } [1]=> array(7) { ["title_en"]=> string(101) "Vislink Reports Fourth Quarter and Full Year 2023 Financial and Operational Results | VISL Stock News" ["snippet_en"]=> string(296) "Vislink Technologies, Inc. reports 75% year-over-year revenue growth in MilGov markets for 2023 and forecasts improved cash flow and significant revenue expansion in 2024. The company achieved key milestones such as acquiring Broadcast Microwave Services, launching Air-to-AnywhereTM, solidifying" ["url"]=> string(118) "https://www.stocktitan.net/news/VISL/vislink-reports-fourth-quarter-and-full-year-2023-financial-and-j0p89330ku8z.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3f8e49fe-ac85-4e30-b734-612d0ac95482" ["source"]=> string(14) "stocktitan.net" ["publication_date"]=> string(10) "2024-03-28" ["categories"]=> array(4) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(18) "Expansion & Growth" [3]=> string(11) "Acquisition" } } [2]=> array(7) { ["title_en"]=> string(97) "Fierce Pharma Asia—BeiGene's 1,400 new hires; BMS' India innovation hub; Evrenzo's China growth" ["snippet_en"]=> string(231) "BeiGene expanded its global workforce by 1,400 over the past 12 months amid fast revenue growth. | BeiGene expanded its global workforce by 1,400 over the past 12 months. Bristol Myers Squibb opened a large innovation hub in India." ["url"]=> string(104) "https://www.fiercepharma.com/pharma/beigene-1400-new-hires-bms-india-innovation-hub-evrenzo-china-growth" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e5b8b29d-8481-4526-90ea-065395f7a383" ["source"]=> string(16) "fiercepharma.com" ["publication_date"]=> string(10) "2024-03-01" ["categories"]=> array(1) { [0]=> string(31) "Financial Update/Profit Warning" } } [3]=> array(7) { ["title_en"]=> string(125) "What are the benefits of product diversification? Bristol-Myers Squibb’s third quarterly report is a textbook demonstration" ["snippet_en"]=> string(445) "Bristol-Myers Squibb (NYSE: BMY) is one of the world's largest healthcare companies. Although it has faced various adverse factors in recent years, such as the loss of market share of its best-selling drug Revlimid and other products, it has still achieved growth and product diversification. Bristol-Myers Squibb's latest quarterly report also proved once again that investors don't need to worry too much about the risks of this medical stock." ["url"]=> string(188) "https://nai500.com/zh-hant/blog/2023/11/%E7%94%A2%E5%93%81%E5%A4%9A%E5%85%83%E5%8C%96-%E5%A5%BD%E8%99%95-%E7%99%BE%E6%99%82%E7%BE%8E%E6%96%BD%E8%B2%B4%E5%AF%B6-%E4%B8%89%E5%AD%A3%E5%A0%B1/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/1c2f459b-7b2f-4a83-a1db-e83e523c8307" ["source"]=> string(10) "nai500.com" ["publication_date"]=> string(10) "2023-11-15" ["categories"]=> array(3) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(15) "Market Movement" } } [4]=> array(7) { ["title_en"]=> string(84) "Here’s Why Madison Sustainable Equity Fund Sold Bristol-Myers Squibb Company (BMY)" ["snippet_en"]=> string(252) "Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. As measured by the S&P 500 Index, the markets were mixed in the third quarter." ["url"]=> string(81) "https://finance.yahoo.com/news/why-madison-sustainable-equity-fund-132440530.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/480c36a7-38a1-45e0-9e8b-2da4b9283cc2" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-10-25" ["categories"]=> array(7) { [0]=> string(19) "Investment Requests" [1]=> string(22) "Sustainable Investment" [2]=> string(12) "Stock Market" [3]=> string(24) "Quarterly/Annual Figures" [4]=> string(31) "Financial Update/Profit Warning" [5]=> string(19) "Green & Responsible" [6]=> string(18) "General Investment" } } [5]=> array(7) { ["title_en"]=> string(128) "S&P 500 stock Bristol-Myers Squibb share: This is how much profit an early investment in Bristol-Myers Squibb would have brought" ["snippet_en"]=> string(101) "This is how much profit an early entry into Bristol-Myers Squibb shares would have brought investors." ["url"]=> string(175) "https://www.finanzen.ch/nachrichten/aktien/s-p-500-titel-bristol-myers-squibb-aktie-so-viel-gewinn-haette-ein-fruehes-investment-in-bristol-myers-squibb-eingefahren-1032623662" ["image_url"]=> string(78) "https://images.businessradar.com/articles/6e676f67-8739-40ea-af38-ecab5e7d1a84" ["source"]=> string(11) "finanzen.ch" ["publication_date"]=> string(10) "2023-09-12" ["categories"]=> array(3) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(18) "General Investment" [2]=> string(12) "Stock Market" } } [6]=> array(7) { ["title_en"]=> string(130) "S&P 500 shares Bristol-Myers Squibb shares: This is how much profit an early investment in Bristol-Myers Squibb would have brought" ["snippet_en"]=> string(96) "Invested in Bristol-Myers Squibb shares years ago: This is how much investors would have earned." ["url"]=> string(175) "https://www.finanzen.ch/nachrichten/aktien/s-p-500-titel-bristol-myers-squibb-aktie-so-viel-gewinn-haette-ein-fruehes-investment-in-bristol-myers-squibb-eingebracht-1032605644" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c9962130-4aac-43e3-a5e9-bef9f2cb7ffe" ["source"]=> string(11) "finanzen.ch" ["publication_date"]=> string(10) "2023-09-05" ["categories"]=> array(4) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(18) "General Investment" [2]=> string(12) "Stock Market" [3]=> string(14) "Issuing Shares" } } [7]=> array(7) { ["title_en"]=> string(128) "S&P 500 stock Bristol-Myers Squibb stock: This is how much profit an early investment in Bristol-Myers Squibb would have yielded" ["snippet_en"]=> string(93) "With an early Bristol-Myers Squibb investment, investors could be happy about that much gain." ["url"]=> string(175) "https://www.finanzen.ch/nachrichten/aktien/s-p-500-papier-bristol-myers-squibb-aktie-so-viel-gewinn-haette-ein-fruehes-investment-in-bristol-myers-squibb-abgeworfen-1032573304" ["image_url"]=> string(78) "https://images.businessradar.com/articles/b4231b9d-9eef-4a6c-bef7-372085ec4c12" ["source"]=> string(11) "finanzen.ch" ["publication_date"]=> string(10) "2023-08-22" ["categories"]=> array(5) { [0]=> string(12) "Stock Market" [1]=> string(12) "Going Public" [2]=> string(31) "Financial Update/Profit Warning" [3]=> string(18) "General Investment" [4]=> string(24) "Stock Research & Ratings" } } [8]=> array(7) { ["title_en"]=> string(82) "BMY Earnings: A snapshot of Bristol-Myers Squibb’s Q2 2023 results | AlphaStreet" ["snippet_en"]=> string(299) "Biotechnology company Bristol Myers Squibb (NYSE: BMY) on Thursday said its second-quarter adjusted earnings decreased year-over-year, hurt by a fall in revenues. Net income attributable to shareholders was$ 2.07 billion or$ 0.99 per share in the June quarter, compared to$ 1.42 billion or$ 0.66 per" ["url"]=> string(94) "https://news.alphastreet.com/bmy-earnings-a-snapshot-of-bristol-myers-squibbs-q2-2023-results/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/63c4044c-5154-4284-85a9-ef98f028e177" ["source"]=> string(15) "alphastreet.com" ["publication_date"]=> string(10) "2023-07-27" ["categories"]=> array(2) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(31) "Financial Update/Profit Warning" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(252) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(165) } [2]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(153) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(94) } [4]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(87) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(77) } [6]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(75) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(64) } [8]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(63) } [9]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(60) } [10]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(60) } [11]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(57) } [12]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(55) } [13]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(47) } [14]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(46) } [15]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(46) } [16]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(45) } [17]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(42) } [18]=> array(2) { ["name"]=> string(8) "Verdicts" ["count"]=> int(41) } [19]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(36) } [20]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(35) } [21]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(34) } [22]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(33) } [23]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(28) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(27) } [25]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [26]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(24) } [27]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(22) } [28]=> array(2) { ["name"]=> string(6) "Energy" ["count"]=> int(22) } [29]=> array(2) { ["name"]=> string(9) "Valuation" ["count"]=> int(21) } } } 81631-us-bristol-myers-squibb-company